Tyrosine Kinase Inhibitors for the Treatment of Thyroid Cancer: Present and Future

Endocrinology&Metabolism International Journal
doi 10.15406/emij.2015.02.00026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MedCrave Group, LLC

Related search

Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer

Journal of the Siena Academy of Sciences
2012English

Tyrosine Kinase Inhibitors: A Foe for the Thyroid?

Journal of Endocrinology and Thyroid Research
2017English

How to Incorporate New Tyrosine Kinase Inhibitors in the Treatment of Patients With Medullary Thyroid Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid Effects of Tyrosine Kinase Inhibitors

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2014English

Tyrosine Kinase Inhibitors in Lung Cancer

Hematology/Oncology Clinics of North America
OncologyHematology
2012English

Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: A Review of Its Incidence, Pathophysiology, Clinical Relevance, and Treatment

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Tyrosine Kinase Inhibitors for Diabetes

Science-Business eXchange
2008English

The Evolving Field of Kinase Inhibitors in Thyroid Cancer

Critical Reviews in Oncology/Hematology
GerontologyGeriatricsHematologyOncology
2015English

Renal Dysfunction in Patients With Radioactive Iodine-Refractory Thyroid Cancer Treated With Tyrosine Kinase Inhibitors

Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy